Erika Minoshima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Erika Minoshima has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Diana Paez
International Atomic Energy Agency
2 shared publications - Akram Al-Ibraheem
Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman 11941, Jordan
1 shared publication - Amalia Peix
Sección de Medicina Nuclear, Instituto de Cardiología y Cirugía Cardiovascular, La Habana, Cuba
1 shared publication - Andrew Mark Scott
Olivia Newton-John Cancer Research Institute, School of Cancer Medicine, La Trobe University, Melbourne, Australia
1 shared publication - Anita Brink
Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, 1400 Vienna, Austria
1 shared publication Anna Veduta
International Atomic Energy Agency Department of Nuclear Sciences and Applications, Division of Human Health, Nuclear Medicine and Diagnostic Imaging Section, Vienna, Austria
1 shared publication
Latest Publications
- Open Access
- 29 July 2024
- Published by Sociedade Brasileira de Cardiologia in International Journal of Cardiovascular Sciences
- Vol. 37
Multimodality Imaging of Chagas Heart Disease: Review and Case Presentation
Chagas disease (CD) is a neglected tropical disease (NTD) caused by Trypanosoma cruzi, a hemoflagellate protozoa. CD is diagnosed by epidemiologic history and two positive serological tests. The infection has two main clinical phases: acute, early after acquiring the infection, and chronic. The electrocardiogram (ECG) is the first tool to diagnose chronic Chagas heart disease after CD serological diagnosis. In addition, the different cardiac imaging modalities, including chest X-ray, echocardiography, single photon emission computed tomography (SPECT), computed tomography (CT), [...] Abstract Chagas disease (CD) is a neglected tropical disease (NTD) caused by Trypanosoma cruzi, a hemoflagellate protozoa. CD is diagnosed by epidemiologic history and two positive serological tests. The infection has two main clinical phases: acute, early after acquiring the infection, and chronic. The electrocardiogram (ECG) is the first tool to diagnose chronic Chagas heart disease after CD serological diagnosis. In addition, the different cardiac imaging modalities, including chest X-ray, echocardiography, single photon emission computed tomography (SPECT), computed tomography (CT),
- 29 July 2024
- Published by Sociedade Brasileira de Cardiologia in International Journal of Cardiovascular Sciences
- Vol. 37
Open AccessMultimodality Imaging of Chagas Heart Disease: Review and Case Presentation
Chagas disease (CD) is a neglected tropical disease (NTD) caused by Trypanosoma cruzi, a hemoflagellate protozoa. CD is diagnosed by epidemiologic history and two positive serological tests. The infection has two main clinical phases: acute, early after acquiring the infection, and chronic. The electrocardiogram (ECG) is the first tool to diagnose chronic Chagas heart disease after CD serological diagnosis. In addition, the different cardiac imaging modalities, including chest X-ray, echocardiography, single photon emission computed tomography (SPECT), computed tomography (CT), [...] Abstract Chagas disease (CD) is a neglected tropical disease (NTD) caused by Trypanosoma cruzi, a hemoflagellate protozoa. CD is diagnosed by epidemiologic history and two positive serological tests. The infection has two main clinical phases: acute, early after acquiring the infection, and chronic. The electrocardiogram (ECG) is the first tool to diagnose chronic Chagas heart disease after CD serological diagnosis. In addition, the different cardiac imaging modalities, including chest X-ray, echocardiography, single photon emission computed tomography (SPECT), computed tomography (CT),
- 29 March 2024
- Published by Elsevier in Journal of Cancer Policy
- Vol. 40, 100471
Six country vignettes: Strengthening radiotherapy and theranostics
- 29 March 2024
- Published by Elsevier in Journal of Cancer Policy
- Vol. 40, 100471
Six country vignettes: Strengthening radiotherapy and theranostics